Admission to Trading
Summary by AI BETAClose X
28 May 2026
Admission to trading of Aviva plc's €575,000,000 Tier 2 Fixed to Floating Rate Notes due November 2057
Aviva plc's (the "Company") €575,000,000 Tier 2 Fixed to Floating Rate Notes due November 2057 (ISIN: XS3318828012) (the "Notes") have been admitted to the Official List of the Financial Conduct Authority (the "FCA") and to trading on the Main Market of the London Stock Exchange on 28 May 2026.
The Notes were issued by the Company under its £7,000,000,000 Euro Note Programme (the "Programme") updated on 11 March 2026. The Final Terms are available for viewing at http://www.rns-pdf.londonstockexchange.com/rns/1087G_3-2026-5-28.pdf.
The Final Terms should be read in conjunction with the Base Prospectus dated 11 March 2026 prepared in respect of the Programme (the "Prospectus"), as supplemented by a Supplemental Prospectus dated 15 May 2026 (the "Supplemental Prospectus"). The Prospectus (which was approved by the FCA on 11 March 2026) is available for viewing at http://www.rns-pdf.londonstockexchange.com/rns/1087G_1-2026-5-28.pdf, and the Supplemental Prospectus (which was approved by the FCA on 15 May 2026) is available for viewing at http://www.rns-pdf.londonstockexchange.com/rns/1087G_2-2026-5-28.pdf.
The Company's LEI is YF0Y5B0IB8SM0ZFG9G81.
-ends-
Enquiries:
|
Media: |
|
|
|
|
|
Andrew Reid |
+44 (0)7800 694 276 |
|
Sarah Swailes |
+44 (0)7800 694 859 |
|
|
|
|
|
|
|
Investors and Analysts: |
|
|
|
|
|
Greg Neilson |
+44 (0)7800 694 564 |
|
|
|
|
|
|
This announcement does not constitute or form part of an offer to sell or the solicitation of an offer to subscribe for or otherwise acquire any securities.
The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or with any securities regulatory authority of any State or other jurisdiction of the United States, and are subject to Unites States tax law requirements. Subject to certain exceptions, the securities referred to herein may not be offered, sold or delivered in the United States (as defined in Regulation S under the Securities Act) or to, or for the account or benefit of, U.S. persons (as defined in the U.S. Internal Revenue Code of 1986, as amended, and regulations thereunder). Neither the Prospectus nor the Supplementary Prospectus may be accessed from, or transmitted in or into, the United States. Accordingly, these securities may not be offered, sold or delivered in the United States.
Please note that the information contained in the Supplemental Prospectus and the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Supplemental Prospectus or the Prospectus you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein.
Your right to access this service is conditional upon complying with the above requirements.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 1 hour ago Oxford Nanopore Technologies
- 2 hours ago AVI Global Trust
- 2 hours ago LSL Property Services
- 2 hours ago Bluebird Merchant Ventures (DI)
- 2 hours ago Power Probe PLC